LULU Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Lululemon is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 who wants a direct entry and is not waiting for a better setup. The stock has some supportive catalysts, but the analyst tone is still mostly neutral, the business is in a reset phase, and the current technicals do not offer a clear high-conviction entry. My clear view: hold, not buy, at this moment.
Price is 131.3 in pre-market, essentially flat. The MACD histogram is positive and expanding, which supports short-term momentum, but RSI_6 at 69.778 is near overbought and moving averages are converging, suggesting the trend is improving but not yet decisive. Key levels matter here: pivot 125.873, resistance 133.327, and stronger resistance 137.933. The stock is trading below first resistance but close enough that upside exists only if momentum continues. Overall, the trend is constructive but not ideal for a beginner long-term entry right now.
Recent news is constructive on governance: Lululemon settled with founder Chip Wilson, ending a proxy battle and reducing an overhang. The company also added new board members and plans to add another apparel expert, which may help strategic execution. Congress trading data is positive with 2 purchase transactions and 0 sales in the last 90 days, suggesting some influential buying interest. The appointment of new CEO Heidi O'Neill is also viewed by some analysts as an incremental positive, even if the impact will take time.
The stock pattern also points to near-term downside pressure, with similar candlestick behavior implying negative returns over the next week and month.
Latest quarter season: fiscal Q4 FY25. Financially, the recent reporting period was mixed to positive: analysts noted solid Q4 results with better-than-expected sales and earnings beat, and gross margin also came in strong. However, Q1 guidance was below expectations and the high end of annual guidance was also light, which reduces confidence in near-term growth. The overall growth picture is stable but not strong enough yet to justify aggressive long-term buying at the current price.
Wall Street is mostly neutral-to-cautious. Baird cut the price target to $170 from $190 and kept Neutral; Barclays kept Equal Weight at $161; Citi lowered to $185; UBS lowered to $176; BNP Paribas lowered to $170; Telsey cut to $175; Stifel lowered to $176 and kept Hold; JPMorgan lowered to $196 and kept Neutral. The broad pros view is that governance changes and a new CEO could improve the story over time. The cons view is stronger: structural headwinds, weak Americas growth, and a 2026 reset narrative keep the stock from being a high-conviction buy.
